4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile

Catalog No. :
ACCGMO825
CAS No. :
475250-43-2
Molecular Formula :
C14H18BNO2
Molecular Weight :
243.12

IUPAC Name:4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile

4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$102.00Login to see priceIn stockIn stock
5g97%$501.00Login to see priceIn stockIn stock
25g97%$1804.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile
IUPAC Name4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile
MDL No.T193517
Molecular FormulaC14H18BNO2
Molecular Weight243.12
SMILESN#CC1=CC=C(CB2OC(C)(C)C(C)(C)O2)C=C1
InChI KeyIBNNFFDCOHDYJE-UHFFFAOYSA-N
Synonym4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile | 475250-43-2 | 4-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]benzonitrile | (4-CYANOBENZYL)BORONIC ACID PINACOL ESTER | DTXSID60452228 | AMY41004 | MFCD18383371 | RB2105 | AKOS016008104 | CS-W021
CAS No.475250-43-2
PubChem CID11021090

Synthetic Route by SureRoute

1. ACCGMO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCGMO825 route product structure diagram
    ACCGMO825475250-43-2 In Stock
Inquiry

2. ACCGMO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEWGX635 route compound structure diagram
    ACEWGX635166330-03-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCGMO825 route product structure diagram
    ACCGMO825475250-43-2 In Stock
Inquiry

Comments (0)